Suchergebnisse - "Oudard, Stephane"

PubPharm (560)

1

Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma

enthalten in: The New England journal of medicine | 2024

von Choueiri, T. | Tomczak, P. | Park, S. | +131

2

Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma : Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Motzer, R. | Porta, C. | Eto, M. | +134

3

Validation of the Lung Immune Prognostic Index (LIPI) as a prognostic biomarker in metastatic renal cell carcinoma

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Carril-Ajuria, L. | Lavaud, P. | Dalban, C. | +19

4

Characterization of Responses to Lenvatinib plus Pembrolizumab in Patients with Advanced Renal Cell Carcinoma at the Final Prespecified Survival Analysis of the Phase 3 CLEAR Study

enthalten in: European urology | 2024

von Motzer, R. | Choueiri, T. | Hutson, T. | +15

5

A Signal-finding Study of Abemaciclib in Heavily Pretreated Patients with Metastatic Castration-Resistant Prostate Cancer : Results from CYCLONE 1

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Agarwal, N. | Castellano, D. | Alonso-Gordoa, T. | +16

6

Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care

enthalten in: British journal of cancer | 2024

von Blanchet, B. | Xu-Vuilard, A. | Jouinot, A. | +21

7

Belzutifan for von Hippel-Lindau Disease : Pancreatic Lesion Population of the Phase 2 LITESPARK-004 Study

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Else, T. | Jonasch, E. | Lliopoulos, O. | +12

8

Prognostic Value of the Modeled Prostate-Specific Antigen KELIM Confirmation in Metastatic Castration-Resistant Prostate Cancer Treated With Taxanes in FIRSTANA

enthalten in: JCO clinical cancer informatics | 2024

von Carrot, A. | Oudard, S. | Colomban, O. | +5

9

Phase II trial of afatinib in patients with advanced urothelial carcinoma with genetic alterations in ERBB1-3 (LUX-Bladder 1)

enthalten in: British journal of cancer | 2024

von Font, A. | Mellado, B. | Climent, M. | +18

10

Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN

enthalten in: British journal of cancer | 2024

von Shen, J. | Chowdhury, S. | Agarwal, N. | +16

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[56]